Tag: IR

Celebration, FL, July 07, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of My Agent Account Version 4.0, a major enhancement to the Company’s proprietary agent platform. The new version, which went live on July 1, 2025, features a fully integrated Transaction Management module that is intended to deliver significant cost savings to the Company by improving efficiency, reducing manual processes, and eliminating reliance on expensive third-party systems.

Reference is made to the announcement by Kvika banki hf. dated 6 July 2025, in which the Board of Kvika approved the initiation of merger discussions with Arion bank hf. 

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, and Dubai's Roads and Transport Authority (RTA) recently held a robotaxi unveiling ceremony in Dubai, formalizing their partnership to advance L4 autonomous mobility solutions.

Vilniaus prekybos ir pramogų centre „Akropolis“ baigtas antrojo aukšto bendrųjų erdvių atnaujinimas. Modernizavus daugiau nei 1500 kv. metrų ploto bendrąsias erdves, lankytojus pasitinka jaukesnė, šviesesnė, patogesnė ir šiuolaikiškai įrengta aplinka. Į interjero atnaujinimą investuota apie 800 tūkst. eurų.

SANTIAGO, Chile, July 04, 2025 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (SSE by nuam: ITAUCL) today announced the release of its first Sustainable Finance Framework (the “Framework”), establishing a comprehensive platform for the issuance of green, social, and sustainability-linked instruments, aligned with leading international standards.

AB „Ignitis grupė“ (toliau – Grupė) informuoja, kad daugumos akcininko teises įgyvendinanti Lietuvos Respublikos finansų ministerija 2025 m. liepos 4 d. paskelbė šešių nepriklausomų Grupės stebėtojų tarybos narių atranką. Atranka vykdoma dėl to, kad 2025 m. spalio 25 d. baigiasi veikiančios stebėtojų tarybos kadencija. Kandidatuoti galima iki 2025 m. liepos 24 d. (imtinai).

Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with Centessa. The milestones were achieved as Centessa initiated clinical development of ORX142, its second novel orexin receptor 2 (OX2R) agonist, following the recent clearance of an Investigational New Drug (IND) application by the US Food and Drug Administration (FDA) for a Phase 1 clinical study of ORX142 in healthy volunteers. (click here).